Relx PLC

Research Relx PLC (REL) on Bullrun: market cap GBX 4.62T, P/E 21.2, dividend yield 2.6%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is GBX 4.62T; P/E is 21.2; dividend yield is 2.6%.

Peer valuation comparison

Latest P/E is 21.22x versus a Industrials sector median of 20.76x (2.2% above).

Latest dividend yield is 2.58% versus a Industrials sector median of 2.39% (7.9% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025GBP 9.59BGBP 2.07BGBP 2.31B66.3%1.12GBP 131.00MGBP 7.27BGBP 2.37B
FY2024GBP 9.43BGBP 1.93BGBP 2.12B65.0%1.03GBP 119.00MGBP 6.54BGBP 3.48B
FY2023GBP 9.16BGBP 1.78BGBP 1.98B64.9%0.94GBP 155.00MGBP 6.50BGBP 3.46B
FY2022GBP 8.55BGBP 1.63BGBP 1.97B64.4%0.85GBP 334.00MGBP 6.73BGBP 3.78B
FY2021GBP 7.24BGBP 1.47BGBP 1.99B64.6%0.76GBP 113.00Mn/aGBP 3.22B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-24GBX 4.62T21.22.6%0.69

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.69 GBX, yield 2.6%.

YearDividends/share
FY202564.3 GBP
FY202460 GBP
FY202355.9 GBP
FY202251.2 GBP
FY202147.7 GBP

About Relx PLC

RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions.

Related stock research

Other Industrials stocks

Frequently asked questions

What is Relx PLC's market cap?

Relx PLC's market capitalization is GBX 4.62T.

What is Relx PLC's P/E ratio?

Relx PLC's price-to-earnings (P/E) ratio is 21.2.

Does Relx PLC pay a dividend?

Relx PLC has a dividend yield of 2.6%.

What does Relx PLC do?

RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk, as well as a portfolio of commercial healthcare products.